{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T11:35:43Z","timestamp":1782819343823,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.ahj.2005.05.024","type":"journal-article","created":{"date-parts":[[2006,5,3]],"date-time":"2006-05-03T08:50:35Z","timestamp":1146646235000},"page":"1072-1079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients\u2014Findings From the International Verapamil SR\/Trandolapril Study (INVEST)"],"prefix":"10.1016","volume":"151","author":[{"given":"Rhonda M.","family":"Cooper-DeHoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Juan M.","family":"Aranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efrain","family":"Gaxiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose L.","family":"Cangiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Garcia-Barreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Richard","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Hewkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl J.","family":"Pepine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2005.05.024_bib1","series-title":"The Hispanic population in the United States: March 2002","year":"2003"},{"key":"10.1016\/j.ahj.2005.05.024_bib2","first-page":"450","article-title":"Race and ethnic standards for Federal statistics and administrative reporting","author":"Wallman","year":"1977","journal-title":"Stat Report"},{"key":"10.1016\/j.ahj.2005.05.024_bib3","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0895-7061(00)00279-X","article-title":"Ethnic differences in nocturnal blood pressure decline in treated hypertensives","volume":"13","author":"Hyman","year":"2000","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ahj.2005.05.024_bib4","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1056\/NEJM199304013281303","article-title":"Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents","volume":"328","author":"Materson","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.05.024_bib5","doi-asserted-by":"crossref","first-page":"22S","DOI":"10.1016\/S0002-9343(96)00265-3","article-title":"The impact of ethnicity on response to antihypertensive therapy","volume":"101","author":"Jamerson","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.ahj.2005.05.024_bib6","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1001\/archinte.1997.00440420033005","article-title":"The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"157","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2005.05.024_bib7","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2005.05.024_bib8","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1001\/jama.290.21.2805","article-title":"A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial","volume":"290","author":"Pepine","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2005.05.024_bib9","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0735-1097(98)00423-9","article-title":"Rationale and design of the International Verapamil SR\/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertension","volume":"32","author":"Pepine","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2005.05.024_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/08037059209077502","article-title":"Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective randomized open blinded end-point","volume":"1","author":"Hansson","year":"1992","journal-title":"Blood Press"},{"key":"10.1016\/j.ahj.2005.05.024_bib11","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1161\/01.HYP.25.3.305","article-title":"Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991","volume":"25","author":"Burt","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2005.05.024_bib12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.290.2.199","article-title":"Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000","volume":"290","author":"Hajjar","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2005.05.024_bib13","first-page":"7","article-title":"Racial\/ethnic disparities in prevalence, treatment, and control of hypertension\u2014United States, 1999-2002","volume":"54","author":"Glover","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ahj.2005.05.024_bib14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1532-5415.2001.49030.x","article-title":"Cardiovascular disease risk factors among older black, Mexican-American, and white women and men: an analysis of NHANES III, 1988-1994. Third National Health and Nutrition Examination Survey","volume":"49","author":"Sundquist","year":"2001","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ahj.2005.05.024_bib15","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2337\/diacare.22.3.403","article-title":"Racial and ethnic differences in glycemic control of adults with type 2 diabetes","volume":"22","author":"Harris","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2005.05.024_bib16","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/oxfordjournals.aje.a116646","article-title":"Health-related risk factors in a sample of Hispanics and whites matched on sociodemographic characteristics. The Stanford Five-City Project","volume":"137","author":"Winkleby","year":"1993","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ahj.2005.05.024_bib17","doi-asserted-by":"crossref","first-page":"29S","DOI":"10.1016\/0002-9343(91)90060-B","article-title":"Hypertension, cardiac disease, and compliance in minority patients","volume":"91","author":"Francis","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.ahj.2005.05.024_bib18","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.287.3.356","article-title":"Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey","volume":"287","author":"Ford","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2005.05.024_bib19","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1001\/jama.1993.03510200070034","article-title":"Mortality by Hispanic status in the United States","volume":"270","author":"Sorlie","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2005.05.024_bib20","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0735-1097(97)00278-7","article-title":"Mortality from coronary heart disease and cardiovascular disease among adult U.S. Hispanics: findings from the National Health Interview Survey (1986 to 1994)","volume":"30","author":"Liao","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2005.05.024_bib21","first-page":"64","article-title":"Acute myocardial infarction and coronary heart disease mortality among Mexican Americans and non-Hispanic whites in Texas, 1980 through 1989","volume":"3","author":"Goff","year":"1993","journal-title":"Ethn Dis"},{"key":"10.1016\/j.ahj.2005.05.024_bib22","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/aje\/kwg249","article-title":"All-cause and cardiovascular mortality among Mexican-American and non-Hispanic white older participants in the San Antonio Heart Study\u2014evidence against the \u201cHispanic paradox\u201d","volume":"158","author":"Hunt","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ahj.2005.05.024_bib23","first-page":"121","article-title":"Disparities in premature deaths from heart disease\u201450 states and the District of Columbia, 2001","volume":"53","author":"Oh","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ahj.2005.05.024_bib24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/01.HYP.23.2.145","article-title":"National High Blood Pressure Education Program Working Group report on hypertension in diabetes","volume":"23","year":"1994","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2005.05.024_bib25","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1001\/jama.290.14.1884","article-title":"Lifetime risk for diabetes mellitus in the United States","volume":"290","author":"Narayan","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2005.05.024_bib26","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1161\/01.HYP.0000125726.92964.ab","article-title":"Adverse prognostic significance of new diabetes in treated hypertensive subjects","volume":"43","author":"Verdecchia","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2005.05.024_bib27","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2005.05.024_bib28","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1365-2796.1992.tb01243.x","article-title":"Diabetes incidence in users and non-users of antihypertensive drugs in relation to serum insulin, glucose tolerance and degree of adiposity: a 12-year prospective population study of women in Gothenburg, Sweden","volume":"231","author":"Bengtsson","year":"1992","journal-title":"J Intern Med"},{"key":"10.1016\/j.ahj.2005.05.024_bib29","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0895-7061(03)00062-1","article-title":"Antihypertensive therapy with verapamil SR plus trandolapril versus atenolol plus chlorthalidone on glycemic control","volume":"16","author":"Holzgreve","year":"2003","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ahj.2005.05.024_bib30","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2337\/diacare.21.4.597","article-title":"Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM","volume":"21","author":"Tatti","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2005.05.024_bib31","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00004872-198907000-00006","article-title":"Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups","volume":"7","author":"Pollare","year":"1989","journal-title":"J Hypertens"},{"key":"10.1016\/j.ahj.2005.05.024_bib32","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0895-7061(01)02140-9","article-title":"Differential effects of ACE-inhibition and angiotensin II antagonism on fibrinolysis and insulin sensitivity in hypertensive postmenopausal women","volume":"14","author":"Fogari","year":"2001","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ahj.2005.05.024_bib33","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2337\/diacare.19.3.226","article-title":"Circulating catecholamines and metabolic effects of captopril in NIDDM patients","volume":"19","author":"De Mattia","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2005.05.024_bib34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting\u2013enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.05.024_bib35","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0140-6736(98)05012-0","article-title":"Effect of angiotensin\u2013converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial","volume":"353","author":"Hansson","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2005.05.024_bib36","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0895-7061(95)00438-6","article-title":"Antihypertensive drug therapy. The effect of JNC criteria on prescribing patterns and patient status through the first year","volume":"9","author":"Alderman","year":"1996","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ahj.2005.05.024_bib37","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/j.1875-9114.1997.tb03089.x","article-title":"Long-acting diltiazem CD is safe and effective in a hypertensive Mexican-American population","volume":"17","author":"Herrera","year":"1997","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ahj.2005.05.024_bib38","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/hy0202.103439","article-title":"Prevalence of hypertension in Hispanic and non-Hispanic white populations","volume":"39","author":"Lorenzo","year":"2002","journal-title":"Hypertension"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870305005272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870305005272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:28:07Z","timestamp":1757568487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870305005272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0002870305005272"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2005.05.024","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients\u2014Findings From the International Verapamil SR\/Trandolapril Study (INVEST)","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2005.05.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}